nominally significantP = 0.021
Nominally significant differences were observed only for gender (72% males in SUDEP group versus 41% in living epilepsy controls, P = 0.021) and convulsive seizures in the 12-month period before last follow-up or death (present in 72% of SUDEP cases versus 42% of living epilepsy controls, P = 0.021).